Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

Saved in:
Bibliographic Details
Title: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
Authors: Motzer RJ (AUTHOR), Escudier B (AUTHOR), Oudard S (AUTHOR), Hutson TE (AUTHOR), Porta C (AUTHOR), Bracarda S (AUTHOR), Grünwald V (AUTHOR), Thompson JA (AUTHOR), Figlin RA (AUTHOR), Hollaender N (AUTHOR), Urbanowitz G (AUTHOR), Berg WJ (AUTHOR), Kay A (AUTHOR), Lebwohl D (AUTHOR), Ravaud A (AUTHOR), RECORD-1 Study Group (CORPORATE AUTHOR)
Source: Lancet. 8/9/2008, Vol. 372 Issue 9637, p449-456. 8p.
Database: Psychology and Behavioral Sciences Collection
Description
ISSN:01406736
DOI:10.1016/s0140-6736(08)61039-9